ks-i

Perfluorinated SAHA is an HDAC inhibitor for use in cancer treatment regimens, with demonstrated greater antiproliferative properties than SAHA . PFSAHA has also been shown to have higher selectivity for PA3774, an HDAC-like enzyme from P. aeruginosa, as well as other HDACs, which may prove beneficial for developing novel chemotherapeutic treatments for cancer.

KSI-3716 是一种 c-Myc 抑制剂，是一种膀胱内化疗剂，阻断 c-MYC/MAX 与靶基因启动子形成复合物，通过诱导细胞周期停滞和细胞凋亡发挥作用，可用于膀胱癌的研究。

KSI-6666作为一种口服有效的竞争性鞘氨醇1-磷酸受体1 (S1PR1) 拮抗剂，其IC50值仅为6.4 nM。在自身免疫性脑脊髓炎模型及T细胞转移性结肠炎模型中，KSI-6666展示了显著的抗炎效果。

PI5P4Ks-IN-2 是磷脂酰肌醇 5-磷酸 4-激酶 PI5P4Kγ 的抑制剂。PI5P4Ks-IN-2 靶向 PI5P4K 亚型，对 PI5P4Kα、PI5P4Kβ、PI5P4Kγ和PI5P4Kγ+具有抑制作用 ，IC50 值分别 <4.3、<4.6、6.2和0.32 。

DYRKs-IN-1 has antitumor activity. DYRKs-IN-1 is a potent DYRKs (Dual-specificity tyrosine-phosphorylation-regulated kinases) inhibitor with IC50s of 9 nM and 5 nM for DYRK1B and DYRK1A, respectively.

DYRKs-IN-2 has antitumor activity. DYRKs-IN-2 is a potent DYRKs inhibitor with IC50s of 30.6 nM and 12.8 nM for DYRK1B and DYRK1A, respectively.

TNKS-IN-3 (Compound 6) 是一种TNKS2抑制剂，其Ki值为8.5 nM，展现出优良活性(IC50: 71 nM)，能够有效抑制WNT/β-catenin信号通路。TNKS-IN-3 可用于研究癌症和纤维化等疾病。

TNKS-IN-41 highly potent and selective inhibitor of tankyrase.

TNKS-IN-1 is a highly potent and selective inhibitor of tankyrase.

PI5P4Ks-IN-1 (compound 7) 是一种与PI5P4Kγ结合的活性化合物。

LDHA/PDKs-IN-2 (compound 20k) 是有效的 LDHA 和 PDKs 的双重抑制剂，IC50 值分别为 0.7 和 1.6 μM。LDHA/PDKs-IN-2 会增加耗氧量并且减少乳酸的形成。LDHA/PDKs-IN-2 显示了癌症研究的潜力，它可以减少 A549 细胞的增殖，EC50值为 15.7 μM。

LDHA/PDKs-IN-1 (compound 20e) is a highly effective dual inhibitor of PDKs and LDHA, displaying IC50 values of 0.8 μM and 0.15 μM, respectively. It significantly suppresses A549 cell proliferation (EC50 = 13.2 μM), reduces lactate formation, and enhances oxygen consumption. This compound holds great promise for cancer research [1].

DYRKs-IN-1 hydrochloride是一种有效的DYRKs(双特异性酪氨酸磷酸化调节激酶)抑制剂，对DYRK1A和DYRK1B的IC50分别为5 nM和8 nM，具有抗肿瘤活性。

SIKs-IN-1（compound 8h）为一种嘧啶-5-羧酰胺衍生物，并充当盐诱导激酶（SIKs）的抑制剂。该化合物通过抑制SIK活性，上调IL-10抗炎细胞因子，下调IL-12促炎细胞因子，调控M1/M2巨噬细胞的极化，并在DSS诱导的结肠炎模型中展现出明显的抗炎效果。

PI5P4Ks-IN-3（化合物30）是一种PI5P4K共价抑制剂，针对PI5P4Kα的IC50为1.34 μM，对PI5P4Kβ的IC50为9.9 μM。然而，PI5P4Ks-IN-3在细胞内的活性较弱。

KS I is a gonadotropin antagonist and is a cyclolignan isolated from extracts of Lycopus and Lithosperum after oxidation with caffeic acid.

HMR 1556 is a chromanol derivative and is an IKs blocker (IC50s of 10.5 nM and 34 nM in canine and guinea pig left ventricular myocytes, respectively).

Diazepinomicin is a secondary metabolite produced by Micromonospora sp. It inhibits the EGF-induced Ras-ERK MAPK signaling pathway and induces apoptosis. Diazepinomicin also is an anti-tumor agent for K-Ras mutant models.

Bitriben is an agent with the anthelmintic effect.

Gentamicin (Centicin) 是一种广谱的氨基糖苷类抗生素，具有抗菌活性，抑制革兰氏阳性菌和革兰氏阴性细菌的生长，可用于研究眼部感染。

Decamethoxine is a biochemical.

KS IV is a cyclolignan isolated from extract of Lycopus and Lithosperum after oxidation with caffeic acid.

PKSI-527 is an inhibitor of plasma kallikrein (Ki = 0.81 μM). It is selective for plasma kallikrein over glandular kallikrein, plasmin, thrombin, urokinase, and Factor Xa (Kis = >500, 390, >500, 200, and >500 μM, respectively). PKSI-527 reduces bradykinin generation induced by kaolin and λ-carrageenan ex vivo in human plasma. It also prolongs partial thromboplastin and euglobulin clot lysis times. In vivo, PKSI-527 (300 mg/kg per day) reduces hyperplasia, pannus formation, and infiltration of inflammatory cells in the tarsal joint of mice with collagen-induced arthritis.

AVSEHQLLHDKGKSIQDLRRRFFLHHLI-{Aib}-EIHTAYRFGG 促进骨化作用。该化合物适用于研究成骨缺陷或骨矿物质密度（BMD）降低相关疾病，如骨质疏松症。